These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10963753)

  • 1. Heterogeneous ligand-mediated Ca(++) responses at wt and mutant alpha(2A)-adrenoceptors suggest multiple ligand activation binding sites at the alpha(2A)-adrenoceptor.
    Pauwels PJ; Colpaert FC
    Neuropharmacology; 2000 Aug; 39(11):2101-11. PubMed ID: 10963753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disparate ligand-mediated Ca(2+) responses by wild-type, mutant Ser(200)Ala and Ser(204)Ala alpha(2A)-adrenoceptor: G(alpha15) fusion proteins: evidence for multiple ligand-activation binding sites.
    Pauwels PJ; Colpaert FC
    Br J Pharmacol; 2000 Aug; 130(7):1505-12. PubMed ID: 10928951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced stability of wild-type and constitutively active alpha(2A)-adrenoceptors by ligands with agonist, silent and inverse agonist properties.
    Pauwels PJ; Tardif S
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):134-41. PubMed ID: 12122500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Facilitation of constitutive alpha(2A)-adrenoceptor activity by both single amino acid mutation (Thr(373)Lys) and g(alphao) protein coexpression: evidence for inverse agonism.
    Pauwels PJ; Tardif S; Wurch T; Colpaert FC
    J Pharmacol Exp Ther; 2000 Feb; 292(2):654-63. PubMed ID: 10640303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of ligand activation of alpha 2-adrenoceptor subtypes under conditions of equal G alpha protein stoichiometry.
    Pauwels PJ; Wurch T; Tardif S; Finana F; Colpaert FC
    Naunyn Schmiedebergs Arch Pharmacol; 2001 May; 363(5):526-36. PubMed ID: 11383713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial to complete antagonism by putative antagonists at the wild-type alpha(2C)-adrenoceptor based on kinetic analyses of agonist:antagonist interactions.
    Pauwels PJ; Colpaert FC
    Br J Pharmacol; 2000 Dec; 131(7):1385-90. PubMed ID: 11090111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-protein activation by putative antagonists at mutant Thr373Lys alpha2A adrenergic receptors.
    Wurch T; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1999 Feb; 126(4):939-48. PubMed ID: 10193774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of ligand responses by coupling of alpha(2A)-adrenoceptors to diverse G(alpha)-proteins.
    Pauwels PJ; Tardif S; Colpaert FC; Wurch T
    Biochem Pharmacol; 2001 May; 61(9):1079-92. PubMed ID: 11301041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism.
    Pauwels PJ; Rauly I; Wurch T
    J Pharmacol Exp Ther; 2003 Jun; 305(3):1015-23. PubMed ID: 12649300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligand-receptor interactions as controlled by wild-type and mutant Thr(370)Lys alpha2B-adrenoceptor-Galpha15 fusion proteins.
    Pauwels PJ; Tardif S; Finana F; Wurch T; Colpaert FC
    J Neurochem; 2000 Jan; 74(1):375-84. PubMed ID: 10617142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for protean agonism of RX 831003 at alpha 2A-adrenoceptors by co-expression with different G alpha protein subunits.
    Pauwels PJ; Rauly I; Wurch T; Colpaert FC
    Neuropharmacology; 2002 May; 42(6):855-63. PubMed ID: 12015212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actions of alpha2 adrenoceptor ligands at alpha2A and 5-HT1A receptors: the antagonist, atipamezole, and the agonist, dexmedetomidine, are highly selective for alpha2A adrenoceptors.
    Newman-Tancredi A; Nicolas JP; Audinot V; Gavaudan S; Verrièle L; Touzard M; Chaput C; Richard N; Millan MJ
    Naunyn Schmiedebergs Arch Pharmacol; 1998 Aug; 358(2):197-206. PubMed ID: 9750005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agonist efficacy at the alpha2A-adrenoceptor:G alpha15 fusion protein: an analysis based on Ca2+ responses.
    Pauwels PJ; Finana F; Tardif S; Colpaert FC; Wurch T
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Jun; 361(6):672-9. PubMed ID: 10882043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonist-directed trafficking of porcine alpha(2A)-adrenergic receptor signaling in Chinese hamster ovary cells: l-isoproterenol selectively activates G(s).
    Brink CB; Wade SM; Neubig RR
    J Pharmacol Exp Ther; 2000 Aug; 294(2):539-47. PubMed ID: 10900230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the interaction of agmatine and crude methanolic extracts of bovine lung and brain with alpha 2-adrenoceptor binding sites.
    Pinthong D; Hussain JF; Kendall DA; Wilson VG
    Br J Pharmacol; 1995 Jun; 115(4):689-95. PubMed ID: 7582492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple alpha 2 adrenergic receptor subtypes. I. Comparison of [3H]RX821002-labeled rat R alpha-2A adrenergic receptors in cerebral cortex to human H alpha2A adrenergic receptor and other populations of alpha-2 adrenergic subtypes.
    Renouard A; Widdowson PS; Millan MJ
    J Pharmacol Exp Ther; 1994 Sep; 270(3):946-57. PubMed ID: 7932207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse agonist activity at the alpha(2A)-adrenergic receptor.
    Wade SM; Lan K; Moore DJ; Neubig RR
    Mol Pharmacol; 2001 Mar; 59(3):532-42. PubMed ID: 11179449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand recognition of serine-cysteine amino acid exchanges in transmembrane domain 5 of alpha2-adrenergic receptors by UK 14,304.
    Cockcroft V; Frang H; Pihlavisto M; Marjamäki A; Scheinin M
    J Neurochem; 2000 Apr; 74(4):1705-10. PubMed ID: 10737629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. S18616, a highly potent, spiroimidazoline agonist at alpha(2)-adrenoceptors: I. Receptor profile, antinociceptive and hypothermic actions in comparison with dexmedetomidine and clonidine.
    Millan MJ; Dekeyne A; Newman-Tancredi A; Cussac D; Audinot V; Milligan G; Duqueyroix D; Girardon S; Mullot J; Boutin JA; Nicolas JP; Renouard-Try A; Lacoste JM; Cordi A
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1192-205. PubMed ID: 11082457
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An asn to lys polymorphism in the third intracellular loop of the human alpha 2A-adrenergic receptor imparts enhanced agonist-promoted Gi coupling.
    Small KM; Forbes SL; Brown KM; Liggett SB
    J Biol Chem; 2000 Dec; 275(49):38518-23. PubMed ID: 10948191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.